Pharmaceutical company Binnopharm Group plans to invest about ₽5 billion in its own development in 2023, said CEO of Binnopharm Group Rustem Muratov. Company is implementing several projects to increase its production capacity. In addition, the company plans to open a new R&D center in the near future, the work in this direction is at the final stage. The top manager also noted that the company is technically ready for an IPO, the timing depends on investor interest.